Louisiana Funds β Full Portfolio
22 tracked investments Β· listed companies and verified rows first
Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures.
BiotechFemTechHealthtechMedical DevicesNew Orleans, US
Joan Neuscheler(Director)Joseph Lovett(Director)Amit Kumar Rathi(Director)Orin Levy(Director)Shuchi Khurana(Executive Officer)Benjamin Cappiello(Executive Officer, Director)
Developing intra-articular ion channel modulator therapeutics for osteoarthritis of the knee.
BiotechShreveport, US
Joseph Lovett(Director)Richard Babb(Treasurer)David Waddell(Director)Ross P. Barrett(Secretary)William R. Grimes(President and Chief Executive Officer)
Dowley designs, installs, and supports unified electronic security systems combining AI-enabled video surveillance, access control, intrusion detection, and analytics into a single managed platform.
AI & Machine LearningCybersecurityHardware
Clinical-stage specialty pharma developing a combination drug to treat a range of addictions, licensed from LSU Health Sciences Center.
Esperance Pharmaceuticals develops targeted anticancer drugs designed to bind specific receptors on cancer cell surfaces and selectively kill cancer cells, including chemotherapy-resistant cells, while sparing normal cells.
BiotechHealthtechHouston, US
Hector Alila(Executive Officer, Director)Ross Barrett(Director)Joseph Lovett(Director)Peter Hoang(Director)Sonia Deggs(Executive Officer)Carola Leuschner(Executive Officer)
Compact micro-tube heat exchanger technology for high-end thermal management in propulsion, electronics, and cooling applications.
Mirata Pharmaceuticals is developing pain-relieving drugs intended to provide the analgesic benefits of opioids without their addictive properties and serious side effects.
BiotechHealthtechPlymouth Meeting, US
John Johnson(Director)Brian Hubbard(Director)Jason Y Zhang(Director)Maurits Geerlings(Director)Matthew Callahan(Executive Officer, Director)
BoardJoseph F Lovett(Director)
Developing 'Epi-drugs' that modulate epigenetic targets for cancer and other diseases.
Omnidek offers a business portal that connects to Sage Intacct to synchronize data and provides a library of configurable workflow and process widgets.
Enterprise SoftwareFuture of WorkSaaSBaton Rouge, US
HUEY NGO(Director)WILLIAM ELLISON(Director)AJOY KRISHNAMOORTHY(Director)STEVEN CHRISTOPHER JORDAN(Executive Officer, Director)
BoardRICHARD BABB(Director)
PRECISIS develops bioelectronic therapies for neurological conditions, including EASEE, a minimally invasive neurostimulation system implanted under the scalp to treat drug-resistant focal epilepsy without brain surgery.
HardwareHealthtechMedical DevicesHeidelberg, DE
Provides solutions for stem cell maintenance, proliferation, differentiation, and large-scale production, including recombinant substrates and antibodies.
Qure4u is an all-in-one digital healthcare platform that enables providers to manage the complete patient journey before, during, and after clinical visits.
Digital HealthHealthtechSaaSBradenton, US
MONICA BOLBJERG(Executive Officer, Director)TORSTEN BOLBJERG(Executive Officer, Director)
Servato develops solutions to manage and improve network power and infrastructure operations, serving customers in telecommunications and related sectors.
EnergyHardwareIoTSaaSNew Orleans, US
JOHN DAVID BARKSDALE(Director)MARK CHRISTOPHER MANGUM(Executive Officer, Director)RONALD LAU(Executive Officer)RONALD ONDECHEK, JR.(Director)JAMES LYONS(Director)Chris Mangum(President & CEO)
Developed the GraftGrab soft tissue fixation device for ACL reconstruction.
TESA Medical operates an online platform listing medical products from brand manufacturers, offering direct sales, consignment, wholesale, retail, and OEM options.
B2B MarketplacesHealthtechMedical Devices
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.